Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers. [electronic resource]
Producer: 20170313Description: 283-96 p. digitalISSN:- 2212-3970
- Animals
- Antineoplastic Agents -- adverse effects
- Clinical Trials as Topic
- Drug Discovery
- Female
- Humans
- Molecular Structure
- Molecular Targeted Therapy
- Phosphatidylinositol 3-Kinase -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- adverse effects
- Signal Transduction -- drug effects
- Structure-Activity Relationship
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.